PAR 1.96% 25.0¢ paradigm biopharmaceuticals limited..

Ann: Trading Halt, page-39

  1. 60 Posts.
    lightbulb Created with Sketch. 10
    It may be worth looking at other bio parma companies that are in a similar situation to PAR to see if they are putting out announcements in regards to the FDA. As if its delays to the approval process PAR will not be the only company affected.
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.